You are here

Article info

Article menu
Download PDFPDF
Review
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases

Authors

  • Gaurav S Gulsin Department of Cardiovascular Sciences, University of Leicester and the Leicester NIHR Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester, UK PubMed articlesGoogle scholar articles
  • Matthew P M Graham-Brown John Walls Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, UK PubMed articlesGoogle scholar articles
  • Iain B Squire Department of Cardiovascular Sciences, University of Leicester and the Leicester NIHR Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester, UK PubMed articlesGoogle scholar articles
  • Melanie J Davies Diabetes Research Centre, University of Leicester and the Leicester NIHR Biomedical Research Centre, Leicester General Hospital, Gwendolen Road, Leicester, UK PubMed articlesGoogle scholar articles
  • Gerry P McCann Department of Cardiovascular Sciences, University of Leicester and the Leicester NIHR Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Gaurav S Gulsin, University of Leicester Department of Cardiovascular Sciences, Leicester, UK; gg149{at}leicester.ac.uk
View Full Text

Citation

Gulsin GS, Graham-Brown MPM, Squire IB, et al
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
Heart 2022;108:16-21.

Publication history

  • Received February 12, 2021
  • Revised March 22, 2021
  • Accepted March 30, 2021
  • First published May 10, 2021.
Online issue publication 
January 11, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.